| First Author | Huang S | Year | 2019 |
| Journal | Viral Immunol | Volume | 32 |
| Issue | 4 | Pages | 161-169 |
| PubMed ID | 31009317 | Mgi Jnum | J:289219 |
| Mgi Id | MGI:6434682 | Doi | 10.1089/vim.2019.0016 |
| Citation | Huang S, et al. (2019) Targeting Peroxisome Proliferator-Activated Receptor-Gamma Decreases Host Mortality After Influenza Infection in Obese Mice. Viral Immunol 32(4):161-169 |
| abstractText | Obesity is an independent risk factor for severe influenza infection. However, the underlying cellular and molecular mechanisms are still incompletely understood. In this study, we have utilized a murine influenza infection model in genetic-induced obese (db/db) mice to explore the mechanisms by which obesity increases host susceptibility to influenza infection. We find that db/db mice have enhanced viral replication, exaggerated inflammatory responses, and dysregulated lung repair process after influenza infection, and consequently increased host mortality. Furthermore, we demonstrate that the transcription factor peroxisome proliferator-activated receptor-gamma (PPAR-gamma), an important inflammation regulator, was downregulated in the lung macrophages of db/db mice after influenza infection. Strikingly, the treatment of 15-deoxy-Delta12, 14-prostaglandin J2 (15d-PGJ2), a PPAR-gamma agonist, largely rescued the survival of db/db mice after influenza infection. Interestingly, macrophage PPAR-gamma-deficient mice exhibited enhanced mortality after influenza infection and 15d-PGJ2 fails to rescue host mortality in macrophage PPAR-gamma-deficient mice, suggesting that PPAR-gamma expression in macrophages is critical for the action of 15d-PGJ2. These data indicate that obesity attenuates lung antiviral immunity and hampers host recovery through the modulation of macrophage PPAR-gamma expression. Furthermore, modalities targeting macrophage PPAR-gamma expression and/or function may serve as promising therapeutics to treat severe influenza infection in obese patients. |
